<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Discussion Paper: Distributed Manufacturing and Point-of-Care Manufacturing of Drugs; Request for Information and Comments</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Discussion Paper: Distributed Manufacturing and Point-of-Care Manufacturing of Drugs; Request for Information and Comments</h1>
    <p class="timestamp">Published: 2022-10-14 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing publication of a discussion paper providing information for stakeholders and soliciting public comments on specific areas of emerging and advanced manufacturing technologies. The discussion paper presents areas for consideration and policy development identified by the Center for Drug Evaluation and Research (CDER) scientific and policy experts associated with distributed manufacturing (DM) and point-of-care (POC) manufacturing for d...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-22386</p>
    <p><strong>Publication Date:</strong> 2022-10-14</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/10/14/2022-22386/discussion-paper-distributed-manufacturing-and-point-of-care-manufacturing-of-drugs-request-for">https://www.federalregister.gov/documents/2022/10/14/2022-22386/discussion-paper-distributed-manufacturing-and-point-of-care-manufacturing-of-drugs-request-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-22386</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
